• Date

  • Content Type

  • Reset


Overcoming Key Regulatory Issues in Cell and Gene Therapies with Reliable and Expansive Expertise


By Emma Cheesman-Ungstrup

For this short interview Emma describes a few of her key takeaways from...


Meeting on the Mesa 2021 | Impact of COVID-19 on the advanced therapies sector


By Christian Schneider, MD

Christian discusses the effects of the COVID-19 pandemic on the advanced therapies sector

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more